Palantir Technologies Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Palantir Technologies (PLTR) is set to report Q2 earnings on August 4, with analysts projecting EPS of $0.14 and revenue of $939.47 million, reflecting significant year-over-year growth. This report follows the company's recent strategic win of a 10-year U.S. Army Enterprise Agreement, potentially valued at up to $10 billion, for future software and data needs. Despite this substantial contract, PLTR shares declined 2.6% on Friday, though several analysts have recently reiterated or initiated positive ratings with price targets ranging up to $178.

Analysis

Palantir Technologies is approaching its Q2 earnings report with high market expectations, as analysts forecast significant year-over-year growth with earnings per share projected to rise from 9 cents to 14 cents and revenue anticipated to climb 38.5% to $939.47 million. This expected financial performance is bolstered by a major strategic victory: a new 10-year Enterprise Agreement with the U.S. Army, holding a potential value of up to $10 billion. Despite this long-term positive catalyst and a strongly positive sentiment signal, PLTR shares recently declined 2.6% to $154.27. Analyst ratings reflect a divided but improving sentiment; while two firms recently initiated or reiterated Buy/Overweight ratings with high price targets of $170 and $178, three other major firms maintain Neutral ratings. Notably, even these neutral analysts have raised their price targets, though the new targets ($90-$115) remain substantially below the stock's current price, highlighting a significant valuation debate ahead of the earnings release.

Key Decisions for Investors

• Investors should monitor the upcoming Q2 earnings report closely, as the company's ability to meet or exceed the high growth expectations of 38.5% in revenue and a 55.6% rise in EPS will be a critical near-term catalyst.
• Consider the long-term growth potential implied by the 10-year U.S. Army contract, but recognize its value is a maximum potential, not a guaranteed revenue stream, and factor this into long-term models.
• Acknowledge the significant divergence between bullish analyst price targets ($170-$178) and more conservative neutral targets ($90-$115), which suggests the stock is a high-conviction name with considerable valuation risk if growth falters.